cytarabine

Generic: cytarabine

Labeler: sagent pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cytarabine
Generic Name cytarabine
Labeler sagent pharmaceuticals
Dosage Form INJECTION, SOLUTION
Routes
INTRATHECAL INTRAVENOUS SUBCUTANEOUS
Active Ingredients

cytarabine 20 mg/mL

Manufacturer
Sagent Pharmaceuticals

Identifiers & Regulatory

Product NDC 25021-229
Product ID 25021-229_e9aed280-7c58-4817-b54d-ccbbdd4af575
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211937
Listing Expiration 2026-12-31
Marketing Start 2023-06-01

Pharmacologic Class

Established (EPC)
nucleoside metabolic inhibitor [epc]
Mechanism of Action
nucleic acid synthesis inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 25021229
Hyphenated Format 25021-229

Supplemental Identifiers

RxCUI
1731355
UNII
04079A1RDZ
NUI
N0000000233 N0000175595

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cytarabine (source: ndc)
Generic Name cytarabine (source: ndc)
Application Number ANDA211937 (source: ndc)
Routes
INTRATHECAL INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 20 mg/mL
source: ndc
Packaging
  • 5 VIAL in 1 CARTON (25021-229-05) / 5 mL in 1 VIAL
source: ndc

Packages (1)

25021-229-05 5 VIAL in 1 CARTON (25021-229-05) / 5 mL in 1 VIAL

Ingredients (1)

cytarabine (20 mg/mL)

Linked Drug Pages (1)

cytarabine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRATHECAL", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "e9aed280-7c58-4817-b54d-ccbbdd4af575", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["04079A1RDZ"], "rxcui": ["1731355"], "spl_set_id": ["90f5c7ab-9f15-487d-ba69-ee4107434bcc"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 VIAL in 1 CARTON (25021-229-05)  / 5 mL in 1 VIAL", "package_ndc": "25021-229-05", "marketing_start_date": "20230601"}], "brand_name": "cytarabine", "product_id": "25021-229_e9aed280-7c58-4817-b54d-ccbbdd4af575", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "25021-229", "generic_name": "cytarabine", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "cytarabine", "active_ingredients": [{"name": "CYTARABINE", "strength": "20 mg/mL"}], "application_number": "ANDA211937", "marketing_category": "ANDA", "marketing_start_date": "20230601", "listing_expiration_date": "20261231"}